A

Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation

Molecular Therapy

Authors 0

  1. Author list not loaded yet.

Cited by 2 stored of 158

2 results

References 0